Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
114.60    3.80 (3.43%)
Bid:
114.80
Ask:
115.60
Spread: 0.80 (0.697%)
Market Cap: £187.88m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Trading Update

2 Jul 2015 07:00

RNS Number : 9208R
Synthomer PLC
02 July 2015
 

2nd July 2015

Synthomer plc

Trading Update

Synthomer plc ('Synthomer' or 'the Group') today issues a Trading Update ahead of its Interim Results on Tuesday 11 August 2015.

Overall, the Board's expectations for the full year remain unchanged.

Europe and North America

In our Q1 trading update, we reported that volumes were slightly behind the same period in 2014. We continued to see a similar trend in Q2, with volumes lower than the prior period primarily due to weaker demand in our Paper and Carpets businesses. As expected, the small margin benefit we experienced in Q1 from declining raw material prices did not continue in Q2, as modest raw material price inflation returned. Overall, operating profit in our Europe and North America segment is marginally behind the prior period in local currency, further behind on a reported basis (H1 2014: £47.8m) due to the weak Euro and consequently slightly behind current market expectations.

Asia and Rest of World

Our Asia and Rest of World segment has continued to experience both improved unit margins and strong demand similar to that seen in the first quarter, particularly in our Asian nitrile business. We have seen good volume growth and substantial margin growth, relative to the weaker performance in the first half of 2014. As a result, operating profit in our Asia and Rest of World segment for the first half of 2015 is materially ahead of the prior period (H1 2014: £7.3m) and current market expectations.

Financial Position

The Group continues to generate strong cash flows from all its operations and this, together with the benefit of the translation of the Euro denominated debt, will result in a further significant reduction in net debt at the end of the first six months. 

The Final 2014 Ordinary Dividend of 4.8p per share and the Special Dividend of 7.8p per share will be paid on 3 July 2015 resulting in a total cash payment to shareholders of approximately £43m.

Outlook

Looking forward to the second half, the economic and currency challenges in Europe are expected to have a continued impact on performance. This will be offset by Asia and Rest of World where, despite some softening in market conditions at the end of the first half, we remain confident of a continued strong performance. Overall, the Board's expectations for the full year remain unchanged.

 

Enquiries:

 

Calum MacLean, Chief Executive Officer

Tel: 01279 436 211

Stephen Bennett, Chief Financial Officer

Tel: 01279 775 250

Charles Armitstead, Pendomer

Tel: 020 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGNVMVGKZM
Date   Source Headline
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue
7th Sep 20237:00 amRNSHalf-year results
18th Jul 20237:00 amRNSPost-close trading update
12th Jul 20233:17 pmRNSAppointment of Non-Executive Director
28th Jun 202312:37 pmRNSDirector/PDMR Shareholding
28th Jun 202312:36 pmRNSDirector/PDMR Shareholding
22nd Jun 202310:20 amRNSDirector/PDMR Shareholding
16th May 20234:00 pmRNSResult of AGM
16th May 20237:00 amRNSAGM trading update
12th May 20231:08 pmRNSDirector/PDMR Shareholding
12th May 20231:06 pmRNSDirector/PDMR Shareholding
13th Apr 202310:02 amRNSHolding(s) in Company
12th Apr 20235:52 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSRefinancing
28th Feb 20233:33 pmRNSDisposal
31st Jan 20237:00 amRNSPost-close update for the year ended 31 Dec 2022
11th Jan 202311:30 amRNSResult of General Meeting
16th Dec 202212:12 pmRNSPublication of Circular &Notice of General Meeting
13th Dec 20227:00 amRNSProposed Sale of Laminates, Films & Coated Fabrics
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSBoard changes
29th Nov 202211:16 amRNSOutcome of European Commission investigation
1st Nov 20222:53 pmRNSHolding(s) in Company
27th Oct 202210:27 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSCovenant relaxation to the end of 2023 agreed
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSInvestor Seminar
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 202210:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.